Modelling tools to characterize acetaminophen pharmacokinetics in the pregnant population

Sofie A.M. Brookhuis*, Karel Allegaert, Lidwien M. Hanff, Marjolijn N. Lub-De Hooge, André Dallmann, Paola Mian

*Corresponding author for this work

Research output: Contribution to journalReview articlePopular

2 Citations (Scopus)
9 Downloads (Pure)

Abstract

This review describes acetaminophen pharmacokinetics (PK) throughout pregnancy, as analyzed by three methods (non-compartmental analyses (NCA), population PK, and physiologically based PK (PBPK) modelling). Eighteen studies using NCA were reported in the scientific liter-ature. These studies reported an increase in the volume of distribution (3.5–60.7%) and an increase in the clearance (36.8–84.4%) of acetaminophen in pregnant women compared to non-pregnant women. Only two studies using population PK modelling as a technique were available in the lit-erature. The largest difference in acetaminophen clearance (203%) was observed in women at delivery compared to non-pregnant women. One study using the PBPK technique was found in the lit-erature. This study focused on the formation of metabolites, and the toxic metabolite N-acetyl-p-benzoquinone imine was the highest in the first trimester, followed by the second and third tri-mester, compared with non-pregnant women. In conclusion, this review gave an overview on acetaminophen PK changes in pregnancy. Also, knowledge gaps, such as fetal and placenta PK param-eters, have been identified, which should be explored further before dosing adjustments can be sug-gested on an evidence-based basis.

Original languageEnglish
Article number1302
JournalPharmaceutics
Volume13
Issue number8
DOIs
Publication statusPublished - 20 Aug 2021

Bibliographical note

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Fingerprint

Dive into the research topics of 'Modelling tools to characterize acetaminophen pharmacokinetics in the pregnant population'. Together they form a unique fingerprint.

Cite this